Telomir Pharmaceuticals, Inc. Common Stock (TELO) SEC Filings: History & Chart

Telomir Pharmaceuticals, Inc. Common Stock(TELO)

Biotechnology · Miami, FL

$1.20-0.01 (-0.83%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Telomir Pharmaceuticals, Inc. Common Stock

Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions. Its primary focus involves the development of TELOMIR-1, an innovative small molecule compound. This oral medication is being engineered to serve as a therapeutic solution against various age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, and also to assist in recovery post-chemotherapy. It achieves this by disrupting and inhibiting inflammatory pathways that are triggered by interleukin-17. Established in 2021, the company was initially known as Metallo Therapies Inc., officially adopting the name Telomir Pharmaceuticals, Inc. on October 10, 2022. The company's headquarters are located in Baltimore, Maryland.

Miami, FL

2 employees

telomirpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Erez Aminov

View full financials

Form	Filing Date	Accepted	Document
8-K	Oct 6, 2026	Oct 6, 2026	View filing
8-K	Sep 17, 2026	Sep 17, 2026	View filing
8-K	Sep 16, 2026	Sep 16, 2026	View filing
8-K	Sep 14, 2026	Sep 14, 2026	View filing
DEFA14A	Aug 19, 2026	Aug 19, 2026	View filing
SC 13G/A	Aug 14, 2026	Aug 14, 2026	View filing
10-Q	Aug 13, 2026	Aug 13, 2026	View filing
8-K	Aug 10, 2026	Aug 10, 2026	View filing
DEF 14A	Jul 28, 2026	Jul 28, 2026	View filing
4	Jul 27, 2026	Jul 27, 2026	View filing
4	Jul 27, 2026	Jul 27, 2026	View filing
4	Jul 27, 2026	Jul 27, 2026	View filing
8-K	Jun 15, 2026	Jun 15, 2026	View filing
3	Jun 9, 2026	Jun 9, 2026	View filing
8-K	Jun 8, 2026	Jun 8, 2026	View filing
4	May 22, 2026	May 22, 2026	View filing
4	May 22, 2026	May 22, 2026	View filing
4	May 22, 2026	May 22, 2026	View filing
4	May 22, 2026	May 22, 2026	View filing
8-K	May 20, 2026	May 20, 2026	View filing
10-Q	May 14, 2026	May 14, 2026	View filing
8-K	Apr 30, 2026	Apr 30, 2026	View filing
4	Apr 24, 2026	Apr 24, 2026	View filing
8-K	Apr 24, 2026	Apr 24, 2026	View filing
8-K	Mar 31, 2026	Mar 31, 2026	View filing
8-K	Mar 31, 2026	Mar 31, 2026	View filing
8-K	Mar 27, 2026	Mar 27, 2026	View filing
10-K	Mar 17, 2026	Mar 17, 2026	View filing
DEFM14A	Feb 19, 2026	Feb 19, 2026	View filing
DEFA14A	Feb 19, 2026	Feb 19, 2026	View filing

SEC Filings

Recent Filings